Literature DB >> 6931550

Eruptive xanthomas associated with isotretinoin (13-cis-retinoic acid).

C H Dicken, S M Connolly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6931550

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  9 in total

Review 1.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

2.  Retinoids. Therapeutic use in dermatology.

Authors:  G L Peck
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 3.  Adverse effects of retinoids.

Authors:  M David; E Hodak; N J Lowe
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

4.  [Eruptive xanthomas with hypertriglyceridemia].

Authors:  R Renner; I Teuwen; W Harth; R Treudler; J C Simon
Journal:  Hautarzt       Date:  2008-12       Impact factor: 0.751

5.  [Eruptive xanthomas].

Authors:  E Roller; K W Schulte; U Hengge; T Ruzicka; A Kuhn; M Megahed
Journal:  Hautarzt       Date:  2004-10       Impact factor: 0.751

Review 6.  Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

7.  The use of gemfibrozil in a patient with chronic myelogenous leukemia to successfully manage retinoid-induced hypertriglyceridemia.

Authors:  P R Cohen
Journal:  Clin Investig       Date:  1993-01

Review 8.  Synthetic retinoids in dermatology.

Authors:  E H Heller; N J Shiffman
Journal:  Can Med Assoc J       Date:  1985-05-15       Impact factor: 8.262

Review 9.  Adverse reactions to oral retinoids. An update.

Authors:  C M Mills; R Marks
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.